Skip to content

Veracyte VCYT Compensation and benefits

Compensation and benefits at other companies

Natera, Inc. logo
Natera, Inc.NTRA
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Agilent Technologies logo
Agilent TechnologiesA
Idexx Laboratories logo
Idexx LaboratoriesIDXX
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
Charles River Laboratories logo
Charles River LaboratoriesCRL

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.29B+10.7%

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's compensation and benefits?
Veracyte (VCYT) reported compensation and benefits of $18.94M in Q1 2026.
How has Veracyte's compensation and benefits changed year-over-year?
Veracyte's compensation and benefits increased by 1.3% year-over-year, from $18.7M to $18.94M.
What is the long-term trend for Veracyte's compensation and benefits?
Over 5 years (2020 to 2025), Veracyte's compensation and benefits has grown at a 24.4% compound annual growth rate (CAGR), from $9.2M to $27.46M.